Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post Exposure Prophylaxis with Hydroxychloroquine in Healthcare Workers Exposed to COVID-19
NCT04437693Phase 3Unknown
- Sponsor
- Hamad Medical Corporation
- Start
- Aug 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by Hamad Medical Corporation. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04437693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04437693.